Empresa Hansa Biopharma AB Nasdaq Stockholm
Acciones
SE0002148817
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Antibody-cleaving Enzyme Technology Platform
100,0
%
| 155 | 100,0 % | 134 | 100,0 % | -13,22 % |
Ventas por región
SEK en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Europe (excluding Sweden)
79,6
%
| 86 | 55,4 % | 107 | 79,6 % | +24,66 % |
North America
20,4
%
| 64 | 41,6 % | 27 | 20,4 % | -57,34 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Søren Tulstrup
CEO | Chief Executive Officer | 59 | 20/03/18 |
Hitto Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/12 |
Achim Kaufhold
CTO | Chief Tech/Sci/R&D Officer | 66 | 29/05/20 |
- | - | ||
Klaus Sindahl
IRC | Investor Relations Contact | - | 29/04/19 |
Matthew Shaulis
PRN | Corporate Officer/Principal | - | 16/03/23 |
Max Sakajja
PRN | Corporate Officer/Principal | 43 | 01/01/17 |
Anne Lanner
HRO | Human Resources Officer | 55 | 18/01/19 |
Vincenza Nigro
PRN | Corporate Officer/Principal | - | 17/09/18 |
Magnus Korsgren
PRN | Corporate Officer/Principal | 55 | 01/04/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 73 | 29/05/18 | |
Peter Nicklin
CHM | Chairman | 61 | 30/06/22 |
Mats Blom
BRD | Director/Board Member | 59 | 22/05/19 |
Eva Nilsagård
BRD | Director/Board Member | 60 | 22/05/19 |
Hilary Malone
BRD | Director/Board Member | 59 | 12/05/21 |
Andreas Eggert
BRD | Director/Board Member | 56 | 29/05/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 2 362 445 | 0 | 2 362 445 ( 100,00 %) | 88,64 % |
Acción B | 1 | 52 443 962 | 48 580 000 ( 92,63 %) | 0 |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
HANSA BIOPHARMA AB 100.00% | 2 598 012 | 100.00% | 7 070 516 $ |
Información de la empresa
Sector
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+17,96 % | 44,96 mil M | |
+1,17 % | 42,65 mil M | |
+48,77 % | 41,85 mil M | |
-4,27 % | 29,04 mil M | |
+11,42 % | 26,08 mil M | |
-21,39 % | 19,03 mil M | |
+4,86 % | 12,75 mil M | |
+27,29 % | 12,06 mil M | |
-3,50 % | 11,75 mil M |